A novel, highly efficient peptide-HLA class I binding assay using unfolded heavy chain molecules: Identification of HIV-1 derived peptides that bind to HLA-A*0201 and HLA-A*0301

Journal of Immunological Methods

Volumn 205, Issue 2, 1997, Pages 201-209

  Tan, T L Raoul ^a   Geluk, Annemieke ^a   Toebes, Mireille ^a   Ottenhoff, Tom H M ^a   Drijfhout, Jan W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

HIV 1; HLA A*0201; HLA A*0301; Peptide binding; Unfolded heavy chain molecules

Indexed keywords

BETA 2 MICROGLOBULIN; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; PEPTIDE; RNA DIRECTED DNA POLYMERASE; VIRUS PROTEIN;

ARTICLE; BINDING AFFINITY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

BETA 2-MICROGLOBULIN; HIV-1 REVERSE TRANSCRIPTASE; HLA-A ANTIGENS; HUMANS; IMMUNOASSAY; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN DENATURATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030825370     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(97)00086-0     Document Type: Article

References (44)

1. Arya, S.K., Gallo, R.C., 1986. Three novel genes of human T-lymphotropic virus type III: Immune reactivity of their products with sera from acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83, 2209.
2. Bjorkman, P.J., Parham, P., 1990. Structure, function, and diversity of class I major histocompatibility complex molecules. Annu. Rev. Biochem. 59, 253.
3. Bjorkman, P.J., Saper, M.A., Samraoui, B., Bennett, W.S., Strominger, J.L., Wiley, D.C., 1987a. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329, 506.
4. Bjorkman, P.J., Saper, M.A., Samraoui, B., Bennett, W.S., Strominger, J.L., Wiley, D.C., 1987b. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329, 512.
5. Bodmer, H.C., Bastin, J.M., Askonas, B.A., Townsend, A.R.M., 1989a. Influenza-specific cytotoxic T-cell recognition is inhibited by peptides unrelated in both sequence and MHC restriction. Immunology 66, 163.
6. Bodmer, J.G., Marsh, S.G.E., Albert, E., 1989b. Nomenclature for factors of the HLA system. Immunol. Today 11, 3.
7. Bodmer, J.G., Marsh, S.G.E., Albert, E.D., Bodmer, W.F., Dupont, B., Erlich, H.A., Mach, B., Mayr, W.R., Parham, P., Sasazuki, T., Schreuder, G.H.T., Strominger, J.L, Svejgaard, A., Terasaki, P., 1990. Nomenclature for factors of the HLA system. Tissue Antigens 37, 1.
8. Burg van der, S.H., Klein, M.R., Velde van der, C.J.H., Kast, W.M., Miedema, F., Melief, C.J.M., 1995a. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase. AIDS 9, 121.
9. Burg van der, S.H., Ras, E., Drijfhout, J.W., Benckhuijsen, W.E., Bremers, A.J.A., Melief, C.J.M., Kast, W.M., 1995b. An HLA class I peptide binding assay based on competition for binding to class I molecules on intact human B cells. Identification of conserved HIV-1 polymerase peptides binding to HLA-A* 0301. Hum. Immunol. 44, 189.
10. Burg van der, S.H., Visseren, M.J.W., Brandt, R.M.P., Kast, W.M., Melief, C.J.M., 1996. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC peptide complex stability. J. Immunol. 156, 3308.
11. Cerundolo, V., Alexander, J., Anderson, K., Creswell, P., McMichael, A., Gotch, F., Townsend, A., 1990. Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature 345, 449.
12. Cerundolo, V., Elliott, T., Elvin, J., Bastin, J., Rammensee, H.G., Townsend, A., 1991. The binding affinity and dissociation rates of peptides for Class I major histocompatibility complex molecules. Eur. J. Immunol. 21, 2069.
13. Cox, A.L., Skipper, J., Chen, Y., Henderson, R.A., Darrow, T.L., Shabanowitz, J., Engelhard, V.H., Hunt, D.F., Slinglaff, C.L., 1994. Identification of a peptide recognized by five melanoma-specific human cytotoxic T-cell lines. Science 264, 716.
14. D'Amaro, J., Houbiers, J.G.A., Drijfhout, J.W., Brandt, R.M.P., Schipper, R., Bouwes Bavinck, J.N., Melief, C.J.M., Kast, W.M., 1995. A computer program for predicting possible cytotoxic T-lymphocyte epitopes based on HLA class I peptide binding motifs. Hum. Immunol. 43, 13.
15. Dillner, J., 1994. Enzyme immunoassay detection of induction of MHC class I expression by synthetic peptides from the E6 and E7 regions of human papillomavirus type 16. J. Immunol. Methods 167, 195.
16. Drijfhout, J.W., Brandt, R.M.P., D'Amaro, J., Kast, W.M., Melief, C.J.M., 1995. Detailed motifs for peptide binding to HLA-A* 0201 derived from large random sets of peptides using a cellular binding assay. Hum. Immunol. 43, 1.
17. Fields, G.B., Noble, R.L., 1990. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Peptide Protein Res. 35, 161.
18. b. Science 257, 919.
19. Garboczi, D.N., Hung, D.T., Wiley, D.C., 1992. HLA-A2 peptide complexes: Refolding and crystallization of molecules expressed in E. coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 89, 3429.
20. Harrer, E., Harrer, T., Barbosa, P., Feinberg, M., Johnson, R.P., Buchbinder, S., Walker, B.D., 1996. Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor. J. Infect. Dis. 173, 476.
21. Heemels, M.T., Ploegh, H.T., 1995. Generation, translocation and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64, 463.
22. Johnson, R.P., Walker, B.D., 1994. Cytotoxic T lymphocytes in human immunodeficiency virus infection: Responses to structural proteins. Curr. Top. Microbiol. Immunol. 189, 35.
23. Latron, F., Pazmany, L., Morrison, J., Moots, R., Saper, M.A., McMichael, A., Strominger, J.L., 1992. A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cells. Science 257, 964.
24. Ljunggren, H.G., Stam, N.J., Ohlen, C., Neefjes, J.J., Höglund, P., Heemels, M.T., Bastin, J., Schumacher, T.N.M., Townsend, A., Kärre, K., Ploegh, H.L., 1990. Empty MHC class I molecules come out in the cold. Nature 346, 476.
25. Matsumara, M., Fremont, D.H., Peterson, P.A., Wilson, I.A., 1992. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257, 927.
26. Milich, D.R., Hughes, J.L., McLachlan, A., Thornton, G.B., Moriarty, A., 1988. Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope. Proc. Natl. Acad. Sci. USA 85, 1610.
27. Myers, G., Wain-Hobson, S., Korber, B., Smith, R.F., Pavlakis, G.N. (Eds.), 1993. Human Retroviruses and AIDS (VolI-II): A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos, NM, Los Alamos National Laboratory.
28. Nayersina, R., Fowler, P., Guilhot, S., Missale, G., Cerny, A., Schilicht, H.J., Vitiello, A., Chestnut, R., Person, J.L., Redeker, A.G., Chisavi, F.V., 1993. HLA-A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol. 150, 4659.
29. Nijman, H.W., Houbiers, J.G.A., Burg van der, S.H., Drijfhout, J.W., D'Amaro, J., Kenemans, P., Melief, C.J.M., Kast, W.M., 1993. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes. Eur. J. Immunol. 23, 1215.
30. Nixon, D.F., McMichael, A.J., 1991. Cytotoxic T-cell recognition of HIV proteins and peptides. Aids 5, 1049.
31. Ottenhoff, T.H.M., Geluk, A., Toebes, M., Benckhuijsen, W.E., van Meijgaarden, K.E., Drijfhout, J.W., 1997. A sensitive fluorometric assay for quantitatively measuring specific peptide binding to HLA class I and class II molecules. J. Immunol. Methods 200, 89.
32. Rammensee, H.G., Friede, T., Stevanovic, S., 1995. MHC ligands and peptide motifs: First listing. Immunogenetics 41, 178.
33. Robbins, P.A., Lettice, L.A., Rota, P., Santos-Aguado, J., Rothbard, J., McMichael, J.J., Strominger, J.L., 1989. Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2. J. Immunol. 143, 4098.
34. Ruppert, J., Sidney, J., Celis, E., Kubo, R.T., Grey, H.M., Sette, A., 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74, 929.
35. Schumacher, T.N.M., Heemels, M.T., Neefjes, J.J., Kast, W.M., Melief, C.J.M., Ploegh, H.L., 1990. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell 62, 563.
36. Sette, A., Sidney, J., del Guerco, M.F., Southwood, S., Ruppert, J., Dahlberg, C., Grey, H.M., Kubo, R.T., 1994. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative binding assays. Mol. Immunol. 31, 813.
37. Sidney, J., Grey, H.M., Kubo, R.T., Sette, A., 1996. Practical, biochemical and evolutionary implications of the discovery of HLA class I super motifs. Immunol. Today 17, 261.
38. Stern, L., Brown, J.H., Jardetzky, T.S., Gorga, J., Urban, R.G., Strominger, J.L., Wiley, D.C., 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368, 215.
39. Storkus, W.J., Zeh, H.J. III, Salter, R.D., Lotze, M.T., 1993. Identification of T-cell epitopes: Rapid isolation of Class I-presented peptides from viable cells by mild acid elution. J. Immunother. 14, 94.
40. Teh, H.S., Kisielow, P., Scott, B., Kishi, H., Uematsu, Y., Bluthmann, H., von Boehmer, H., 1988. Thymic major histocompatibility complex antigens and the αβ T cell receptor determine the CD4/CD8 phenotype of T cells. Nature 335, 229.
41. Townsend, A., Elliott, T., Cerundolo, V., Foster, L., Barber, B., Tse, A., 1990. Assembly of MHC class I molecules analyzed in vitro. Cell 62, 285.
42. Walker, B.D., Flexner, C., Birch-Limberger, K., Fisher, L., Paradis, T.J., Aldorini, A., Young, R., Moss, B., Schooley, R.T., 1989. Long term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type a. Proc. Natl. Acad. Sci. USA 86, 9514.
43. Wolfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Meyer zum Buschenfelde, K.H., Boon, T., 1994. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol. 24, 759.
44. Zeh, H.J. III, Leder, G.H., Lotze, M.T., Salter, R.D., Tector, M., Stuber, G., Modrow, S., Storkus, W.J., 1994. Flow-cytometric determination of peptide-class I complex formation; Identification of p53 peptides that bind to HLA-A2. Hum. Immunol. 39, 79.